VentriPoint Diagnostics (CVE:VPT) Shares Down 12.5%

VentriPoint Diagnostics Ltd. (CVE:VPT)’s share price fell 12.5% during trading on Thursday . The stock traded as low as C$0.07 and last traded at C$0.07, 560,650 shares traded hands during trading. An increase of 211% from the average session volume of 180,473 shares. The stock had previously closed at C$0.08.

The firm has a 50-day moving average of C$0.10 and a two-hundred day moving average of C$0.12. The company has a market capitalization of $6.87 million and a PE ratio of -1.31.

VentriPoint Diagnostics Company Profile (CVE:VPT)

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers.

See Also: Blockchain

Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.